Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.30 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31563093 | 0.83 | MAPT (0.50) | SMN1; SMN2MAPTHTTPOLBMEN1 | |
| SCHEMBL31563030 | 0.83 | ALDH1A1 (0.43) | RAB9ASMN1; SMN2MAPTHTTMEN1 | |
| SCHEMBL31563510 | 0.78 | NPC1 (0.50) | RAB9ASMN1; SMN2MAPTHTTPOLB | |
| SCHEMBL6893764 | 0.78 | MAPT (0.50) | RAB9ASMN1; SMN2MAPTHTTPOLB | |
| SCHEMBL14921880 | 0.78 | RAB9A (0.50) | RAB9ASMN1; SMN2MAPTHTTPOLB | |
| SCHEMBL14932943 | 0.77 | HTT (0.39) | RAB9ASMN1; SMN2HTTPOLBMEN1 | |
| SCHEMBL31080641 | 0.76 | KMT2A (0.48) | RAB9ASMN1; SMN2MAPTHTTPOLB | |
| SCHEMBL13509390 | 0.75 | MAPT (0.33) | RAB9ASMN1; SMN2MAPTHTTPOLB | |
| SCHEMBL10136752 | 0.75 | MAPT (0.33) | RAB9ASMN1; SMN2MAPTHTTPOLB | |
| SCHEMBL31563118 | 0.73 | MAPT (0.45) | RAB9ASMN1; SMN2MAPTHTTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025077773-A1 | NOVEL TYPE I TOPOISOMERASE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 上海翊维康医药有限责任公司 | 2025-04-17 | — | — | WO | disclosed |